LeonaBio (LONA) Cash & Current Investments (2019 - 2026)

LeonaBio (LONA) has 8 years of Cash & Current Investments data on file, last reported at $67.7 million in Q1 2026.

• Quarterly Cash & Current Investments rose 84.56% year-over-year to $67.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.7 million (up 84.56% YoY) and the FY2025 annual result came in at $88.3 million, up 72.27% from the prior year.
• Cash & Current Investments eased to $67.7 million in Q1 2026 per LONA's latest filing, from $88.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $263.5 million in Q1 2022 and bottomed at $25.2 million in Q3 2025.
• The 5-year median for Cash & Current Investments is $122.1 million (2024), against an average of $130.0 million.
• The widest annual swing landed in 2025, when Cash & Current Investments sank 69.96%; it then jumped 84.56% in 2026.
• Tracing LONA's Cash & Current Investments over 5 years: stood at $200.3 million in 2022, then slipped by 26.42% to $147.4 million in 2023, then tumbled by 65.22% to $51.3 million in 2024, then surged by 72.27% to $88.3 million in 2025, then slipped by 23.38% to $67.7 million in 2026.
• Per Business Quant, the three latest LONA Cash & Current Investments figures stand at $67.7 million (Q1 2026), $88.3 million (Q4 2025), and $25.2 million (Q3 2025).

Peer Comparison